Novavax, Inc.

NasdaqGS NVAX

Novavax, Inc. Inventory for the quarter ending September 30, 2024: USD 8.64 M

Novavax, Inc. Inventory is USD 8.64 M for the quarter ending September 30, 2024, a -87.59% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Novavax, Inc. Inventory for the quarter ending September 30, 2023 was USD 69.59 M, a -15.58% change year over year.
Novavax, Inc. Inventory for the quarter ending September 30, 2022 was USD 82.43 M, a 908.34% change year over year.
Novavax, Inc. Inventory for the quarter ending September 30, 2021 was USD 8.18 M, a -87.83% change year over year.
Novavax, Inc. Inventory for the quarter ending September 30, 2020 was USD 67.15 M, a 0.00% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

NasdaqGS: NVAX

Novavax, Inc.

CEO	Mr. John Charles Jacobs M.B.A.
IPO Date	Dec. 5, 1995
Location	United States
Headquarters	21 Firstfield Road
Employees	1,543
Sector	Healthcare
Industries Vaccines Biotechnology

Description

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Key trends

Past 5 years